GeneDx Holdings Corp. Class A Share Price
NASDAQ: WGS | Mid CapGeneDx Holdings Corp. Class A Stock Performance
GeneDx Holdings Corp. Class A Share Price Today
As of 11 September 2026, GeneDx Holdings Corp. Class A's share price is $83.98. The stock opened at $84.52, compared to its previous close of $86.58. During today's trading session, GeneDx Holdings Corp. Class A's share price traded between $83.50 and $87.10, with an average price of $85.30. Over the past 52 weeks, the stock has recorded a high of $170.36 and a low of $32.33. In terms of performance, GeneDx Holdings Corp. Class A's share price has risen by 30.64% over the last six months and is down 22.14% on a year-on-year basis.
GeneDx Holdings Corp. Class A Share Price Chart
GeneDx Holdings Corp. Class A Quarterly Profit & Loss
All figures in USD
GeneDx Holdings Corp. Class A Annual Profit & Loss
All figures in USD
About GeneDx Holdings Corp. Class A
GeneDx Holdings Corp., a genomics company, provides genetic testing services. It primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. The company also develops an AI-based platform for NGS analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. The company is headquartered in Stamford, Connecticut.
GeneDx Holdings Corp. Class A Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Sep 2026 | $83.91 | $86.58 | -2.99% |
Aug 2026 | $65.72 | $89.25 | +37.22% |
Jul 2026 | $70.32 | $65.04 | -5.36% |
Jun 2026 | $51.69 | $68.72 | +32.47% |
May 2026 | $63.88 | $51.88 | -17.37% |
Apr 2026 | $65.91 | $62.78 | -2.34% |
Mar 2026 | $78.36 | $64.28 | -19.25% |
Feb 2026 | $96.73 | $79.61 | -17.24% |
Jan 2026 | $131.79 | $96.19 | -26.01% |
Dec 2025 | $161.47 | $130.01 | -21.60% |
Nov 2025 | $138.60 | $165.82 | +21.65% |
Oct 2025 | $108.31 | $136.31 | +26.36% |